Atlas Trials

Study to Explore the Effect of Mefloquine in Participants With Progressive Multifocal Leukoencephalopathy (PML)

Clinical trial NCT00746941 · TERMINATED

Trial details

NCT number
NCT00746941
Sponsor
Biogen
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Progressive Multifocal Leukoencephalopathy
Start date
2009-01-01
Primary completion
2010-11-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.